Evaluation of bendamustine in combination with fludarabine in primary chronic lymphocytic leukemia cells

The fludarabine and cyclophosphamide couplet has become the backbone of the chronic lymphocytic leukemia (CLL) standard of care. Although this is an effective treatment, it results in untoward toxicity. Bendamustine is a newly approved and better-tolerated alkylating agent. We hypothesized that simi...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: El-Mabhouh, Amal A., Ayres, Mary L., Shpall, Elizabeth J., Baladandayuthapani, Veerabhadran, Keating, Michael J., Wierda, William G., Gandhi, Varsha
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Hematology 2014
Pynciau:
Lymphoid Neoplasia
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4055925/
https://ncbi.nlm.nih.gov/pubmed/24747434
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-12-541433
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg